Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-17

Clinical Trial Update: Mitigation Efforts in Arsenic Exposure With Folic Acid Supplementation [NA]

View source ↗

Summary

A clinical trial is enrolling by invitation to assess whether folic acid supplementation mitigates adverse effects from arsenic exposure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • folic acid (folic acid)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Arsenic and/or Arsenic Compound Adverse Reaction | NA | Status: ENROLLING_BY_INVITATION